BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37160317)

  • 21. A case of familial transmission of the newly described DNMT3A-Overgrowth Syndrome.
    Lemire G; Gauthier J; Soucy JF; Delrue MA
    Am J Med Genet A; 2017 Jul; 173(7):1887-1890. PubMed ID: 28449304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia.
    Ali AM; Salih GF
    Mol Biol Rep; 2022 Dec; 49(12):11685-11693. PubMed ID: 36175738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.
    Jeffries AR; Maroofian R; Salter CG; Chioza BA; Cross HE; Patton MA; Dempster E; Temple IK; Mackay DJG; Rezwan FI; Aksglaede L; Baralle D; Dabir T; Hunter MF; Kamath A; Kumar A; Newbury-Ecob R; Selicorni A; Springer A; Van Maldergem L; Varghese V; Yachelevich N; Tatton-Brown K; Mill J; Crosby AH; Baple EL
    Genome Res; 2019 Jul; 29(7):1057-1066. PubMed ID: 31160375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report.
    Mordoh A; Triviño Pardo JC; Carri I; Barrio MM; Mordoh J; Aris M
    BMC Med Genomics; 2023 Jan; 16(1):1. PubMed ID: 36604730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
    Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
    Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An adult patient with Tatton-Brown-Rahman syndrome caused by a novel DNMT3A variant and axonal polyneuropathy.
    AlSabah AA; Alsalmi M; Massie R; Bilodeau MC; Campeau PM; McGraw S; D'Agostino MD
    Am J Med Genet A; 2024 Apr; 194(4):e63484. PubMed ID: 38041495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First identified Korean family with Tatton-Brown-Rahman Syndrome caused by the novel DNMT3A variant c.118G>C p.(Glu40Gln).
    Lee CG; Jang JH; Seo JY
    Ann Pediatr Endocrinol Metab; 2019 Dec; 24(4):253-256. PubMed ID: 31905446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNMT3A in Leukemia.
    Brunetti L; Gundry MC; Goodell MA
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 28003281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
    Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
    J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY; Mirkin BL; Dwivedi RS
    Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
    Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
    BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers.
    Kim MS; Kim YR; Yoo NJ; Lee SH
    APMIS; 2013 Feb; 121(2):85-94. PubMed ID: 23031157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Base-Resolution Analysis of DNA Methylation Patterns Downstream of
    Duncan CG; Kondilis-Mangum HD; Grimm SA; Bushel PR; Chrysovergis K; Roberts JD; Tyson FL; Merrick BA; Wade PA
    G3 (Bethesda); 2018 Mar; 8(3):805-813. PubMed ID: 29326230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epigenetic dysregulation in myelodysplastic syndromes].
    Sashida G
    Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.
    Kim G; Kim JY; Lim SC; Lee KY; Kim O; Choi HS
    FASEB J; 2018 Oct; 32(10):5647-5660. PubMed ID: 29750576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of G-Quadruplex Structures on Methylation of Model Substrates by DNA Methyltransferase Dnmt3a.
    Loiko AG; Sergeev AV; Genatullina AI; Monakhova MV; Kubareva EA; Dolinnaya NG; Gromova ES
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remethylation of
    Ketkar S; Verdoni AM; Smith AM; Bangert CV; Leight ER; Chen DY; Brune MK; Helton NM; Hoock M; George DR; Fronick C; Fulton RS; Ramakrishnan SM; Chang GS; Petti AA; Spencer DH; Miller CA; Ley TJ
    Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3123-3134. PubMed ID: 31996479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming.
    Na F; Pan X; Chen J; Chen X; Wang M; Chi P; You L; Zhang L; Zhong A; Zhao L; Dai S; Zhang M; Wang Y; Wang B; Zheng J; Wang Y; Xu J; Wang J; Wu B; Chen M; Liu H; Xue J; Huang M; Gong Y; Zhu J; Zhou L; Zhang Y; Yu M; Tian P; Fan M; Lu Z; Xue Z; Zhao Y; Yang H; Zhao C; Wang Y; Han J; Yang S; Xie D; Chen L; Zhong Q; Zeng M; Lowe SW; Lu Y; Liu Y; Wei Y; Chen C
    Nat Cancer; 2022 Jun; 3(6):753-767. PubMed ID: 35449309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.